The CDC and FDA have advised that certain immunocompromised individuals should receive 1 booster dose (or third shot) of COVID-19 vaccination at least four weeks after a second dose of Pfizer or Moderna vaccination.
This booster is recommended for moderately to severely immunocompromised people who have:
- Been receiving active cancer treatment for tumors or cancers of the blood
- Received an organ transplant and are taking medicine to suppress the immune system
- Received a stem cell transplant within the last 2 years or are taking medicine to suppress the immune system
- Moderate or severe primary immunodeﬁciency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)
- Advanced or untreated HIV infection
- Active treatment with high-dose corticosteroids or other drugs that may suppress your immune response
These recommendations only apply to individuals who have received one of the mRNA vaccines (Pfizer or Moderna). There are currently no guidelines for additional doses for individuals who have received the J&J (Janssen) vaccine.
Getting the 3rd Booster
Individuals should be vaccinated with whichever vaccine they received for their initial two-dose series.
Individuals who qualify for the booster vaccines should:
- Schedule your appointment
- Be prepared to sign an attestation that they have an immunocompromised state and consent for vaccination.
- Bring their Vaccine Cards to be updated with the booster dose
Side effects from this third vaccination are similar to those experienced during the initial two-dose series including: injection site pain or redness, fatigue, low-grade fevers, and muscle aches which are generally mild to moderate.